31P Magnetic resonance spectroscopic imaging with polarisation transfer of phosphomono‐ and diesters at 3 T in the human brain: relation with age and spatial differences

Tissue levels of the compounds phosphocholine (PC), phosphoethanolamine (PE), glycerophosphocholine (GPC) and glycerophosphoethanolamine (GPE) can be studied by in vivo 31P MRS. However, the detection of the signals of these compounds suffers from low sensitivity and contamination by underlying broad resonances of other phosphorylated compounds. Improved sensitivity without this contamination can be achieved with a method for optimal polarisation transfer of 1H to 31P spins in these molecules, called selective refocused insensitive nuclei‐enhanced polarisation transfer (sRINEPT). The aim of this study was to implement a three‐dimensional magnetic resonance spectroscopic imaging (MRSI) version of sRINEPT on a clinical 3 T magnetic resonance system to obtain spatially resolved relative levels of PC, PE, GPC and GPE in the human brain as a function of age, which could be used as a reference dataset for clinical applications. Good signal‐to‐noise ratios were obtained from voxels of 17 cm3 of the parietal and occipital lobes of the brain within a clinically acceptable measurement time of 17 min. Eighteen healthy subjects of different ages (16–70 years) were examined with this method. A strong inverse relation of the PE/GPE and PC/GPC ratios with age was found. Spatial resolution was sufficient to detect differences in metabolite ratios between white and grey matter. Moreover, we showed the feasibility of this method for clinical use in a pilot study of patients with brain tumours. The sRINEPT MRSI technique enables the exploration of phospholipid metabolism in brain diseases with a better sensitivity than was possible with earlier 31P MRS methods. Copyright © 2010 John Wiley & Sons, Ltd.

[1]  Nicholas Lange,et al.  Age‐related changes in brain energetics and phospholipid metabolism , 2010, NMR in biomedicine.

[2]  J. Pascual,et al.  Assessment of 31P‐NMR analysis of phospholipid profiles for potential differential diagnosis of human cerebral tumors , 2009, NMR in biomedicine.

[3]  C. Studholme,et al.  Mapping of brain metabolite distributions by volumetric proton MR spectroscopic imaging (MRSI) , 2009, Magnetic resonance in medicine.

[4]  A. Heerschap,et al.  Efficient 1H to 31P polarization transfer on a clinical 3T MR system , 2008, Magnetic resonance in medicine.

[5]  R. Mrak,et al.  31P NMR spectroscopy of phospholipid metabolites in postmortem schizophrenic brain , 2008, Magnetic resonance in medicine.

[6]  D. Graveron-Demilly,et al.  Java-based graphical user interface for the MRUI quantitation package , 2001, Magnetic Resonance Materials in Physics, Biology and Medicine.

[7]  Ravi S. Menon,et al.  Grey and white matter differences in brain energy metabolism in first episode schizophrenia: 31P-MRS chemical shift imaging at 4 Tesla , 2006, Psychiatry Research: Neuroimaging.

[8]  M. van der Graaf,et al.  Sensitivity‐enhanced 13C MR spectroscopy of the human brain at 3 Tesla , 2006, Magnetic resonance in medicine.

[9]  N. Bresolin,et al.  Parkinson's Disease and Brain Mitochondrial Dysfunction: A Functional Phosphorus Magnetic Resonance Spectroscopy Study , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[10]  Marvin D Nelson,et al.  Proton‐decoupled 31P MRS in untreated pediatric brain tumors , 2005, Magnetic resonance in medicine.

[11]  Arend Heerschap,et al.  Fast acquisition‐weighted three‐dimensional proton MR spectroscopic imaging of the human prostate , 2004, Magnetic resonance in medicine.

[12]  L. Mancini,et al.  Comparison of polarization transfer sequences for enhancement of signals in clinical 31P MRS studies , 2003, Magnetic resonance in medicine.

[13]  Heinrich Lanfermann,et al.  Increased choline levels coincide with enhanced proliferative activity of human neuroepithelial brain tumors , 2002, NMR in biomedicine.

[14]  Arend Heerschap,et al.  Maturation of the human fetal brain as observed by 1H MR spectroscopy , 2002, Magnetic resonance in medicine.

[15]  Ravi S. Menon,et al.  In vivo brain 31P‐MRS: measuring the phospholipid resonances at 4 Tesla from small voxels , 2002, NMR in biomedicine.

[16]  Ravi S. Menon,et al.  Region-specific changes in phospholipid metabolism in chronic, medicated schizophrenia , 2002, British Journal of Psychiatry.

[17]  P F Renshaw,et al.  Multinuclear magnetic resonance spectroscopy studies of brain purines in major depression. , 2001, The American journal of psychiatry.

[18]  R Pohmann,et al.  Accurate phosphorus metabolite images of the human heart by 3D acquisition‐weighted CSI , 2001, Magnetic resonance in medicine.

[19]  J J Mallet,et al.  Regional differences and metabolic changes in normal aging of the human brain: proton MR spectroscopic imaging study. , 2001, AJNR. American journal of neuroradiology.

[20]  F. Podo Tumour phospholipid metabolism , 1999, NMR in biomedicine.

[21]  S. Blüml,et al.  Developmental changes in choline‐ and ethanolamine‐containing compounds measured with proton‐decoupled 31P MRS in in vivo human brain , 1999, Magnetic resonance in medicine.

[22]  Jens Frahm,et al.  Regional Age Dependence of Human Brain Metabolites from Infancy to Adulthood as Detected by Quantitative Localized Proton MRS , 1999, Pediatric Research.

[23]  K O Lim,et al.  In vivo spectroscopic quantification of the N‐acetyl moiety, creatine, and choline from large volumes of brain gray and white matter: Effects of normal aging , 1999, Magnetic resonance in medicine.

[24]  Vanhamme,et al.  Improved method for accurate and efficient quantification of MRS data with use of prior knowledge , 1997, Journal of magnetic resonance.

[25]  T R Brown,et al.  In vivo phosphorus polarization transfer and decoupling from protons in three‐dimensional localized nuclear magnetic resonance spectroscopy of human brain , 1997, Magnetic resonance in medicine.

[26]  D J Jenden,et al.  In vivo proton magnetic resonance spectroscopy of the normal aging human brain. , 1996, Life sciences.

[27]  T R Brown,et al.  NOE Enhancements and T1 Relaxation Times of Phosphorylated Metabolites in Human Calf Muscle at 1.5 Tesla , 1995, Magnetic resonance in medicine.

[28]  Peter Boesiger,et al.  Assessment of absolute metabolite concentrations in human tissue by 31P MRS in vivo. Part I: Cerebrum, cerebellum, cerebral gray and white matter , 1994, Magnetic resonance in medicine.

[29]  J. Pettegrew,et al.  Alterations of cerebral metabolism in probable Alzheimer's disease: A preliminary study , 1994, Neurobiology of Aging.

[30]  Roland Kreis,et al.  Development of the human brain: In vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy , 1993, Magnetic resonance in medicine.

[31]  W. Negendank,et al.  Studies of human tumors by MRS: A review , 1992, NMR in biomedicine.

[32]  G Friedmann,et al.  Human brain tumors: spectral patterns detected with localized H-1 MR spectroscopy. , 1992, Radiology.

[33]  J. Pettegrew,et al.  Changes in Brain Energy and Phospholipid Metabolism During Development and Aging in the Fischer 344 Rat , 1990, Journal of neuropathology and experimental neurology.

[34]  G B Matson,et al.  P-31 MR spectroscopy of normal human brain and brain tumors. , 1990, Radiology.

[35]  P R Luyten,et al.  Broadband proton decoupling in human 31p NMR spectroscopy , 1989, NMR in biomedicine.

[36]  D. Arnold,et al.  MR image-guided P-31 MR spectroscopy in the evaluation of brain tumor treatment. , 1987, Radiology.

[37]  N. Minshew,et al.  31P Nuclear Magnetic Resonance Studies of Phosphoglyceride Metabolism in Developing and Degenerating Brain: Preliminary Observations , 1987, Journal of neuropathology and experimental neurology.

[38]  A. Overhauser Polarization of Nuclei in Metals , 1953 .